Enlivex Therapeutics Analyst Ratings
Enlivex Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/25/2023 | 721.92% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 08/01/2023 | 927.4% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 04/24/2023 | 927.4% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 04/05/2023 | 927.4% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 02/24/2023 | 927.4% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 05/02/2022 | 927.4% | HC Wainwright & Co. | $33 → $15 | Maintains | Buy |
| 01/09/2020 | 1269.86% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/25/2023 | 721.92% | HC Wainwright公司 | $15→$12 | 維護 | 買 |
| 08/01/2023 | 927.4% | HC Wainwright公司 | →$15 | 重申 | 購買→購買 |
| 04/24/2023 | 927.4% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 04/05/2023 | 927.4% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 02/24/2023 | 927.4% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 05/02/2022 | 927.4% | HC Wainwright公司 | $33→$15 | 維護 | 買 |
| 1/09/2020 | 1269.86% | HC Wainwright公司 | →$20 | 開始承保 | →購買 |
What is the target price for Enlivex Therapeutics (ENLV)?
Enlivex治療公司(ENLV)的目標價格是多少？
The latest price target for Enlivex Therapeutics (NASDAQ: ENLV) was reported by HC Wainwright & Co. on September 25, 2023. The analyst firm set a price target for $12.00 expecting ENLV to rise to within 12 months (a possible 721.92% upside). 5 analyst firms have reported ratings in the last year.
埃利維斯治療公司(納斯達克代碼：ENLV)的最新目標價是由HC Wainwright&Co.於2023年9月25日報道的。這家分析公司將目標價定為12美元，預計ENLV將在12個月內升至(可能上漲721.92%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Enlivex Therapeutics (ENLV)?
Enlivex治療公司(ENLV)的最新分析師評級是多少？
The latest analyst rating for Enlivex Therapeutics (NASDAQ: ENLV) was provided by HC Wainwright & Co., and Enlivex Therapeutics maintained their buy rating.
對伊利韋克斯治療公司(納斯達克代碼：ENLV)的最新分析師評級由HC Wainwright&Co.提供，伊利韋克斯治療公司維持其買入評級。
When is the next analyst rating going to be posted or updated for Enlivex Therapeutics (ENLV)?
Enlivex治療公司(ENLV)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enlivex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enlivex Therapeutics was filed on September 25, 2023 so you should expect the next rating to be made available sometime around September 25, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Enlivex治療公司的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Enlivex治療公司的上一次評級是在2023年9月25日提交的，所以你應該預計下一次評級將在2024年9月25日左右的某個時候提供。
Is the Analyst Rating Enlivex Therapeutics (ENLV) correct?
分析師對Enlivex Treeutics(ENLV)的評級正確嗎？
While ratings are subjective and will change, the latest Enlivex Therapeutics (ENLV) rating was a maintained with a price target of $15.00 to $12.00. The current price Enlivex Therapeutics (ENLV) is trading at is $1.46, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Enlivex Treeutics(ENLV)評級保持不變，目標價在15.00美元至12.00美元之間。Enlivex治療公司(ENLV)目前的交易價格為1.46美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。